Literature DB >> 26171170

Tetra-arsenic tetra-sulfide induces cell cycle arrest and apoptosis in retinoic acid-resistant acute promyelocytic leukemia cells.

Yuan Wang1, Peng-Cheng He1, Jun Qi2, Yan-Feng Liu1, Mei Zhang1.   

Abstract

Previous studies have shown that the therapeutic action of tetra-arsenic tetra-sulfide (As4S4) is effective for acute promyelocytic leukemia. However, the molecular mechanism of the action of As4S4 in retinoic acid-resistant acute promyelocytic leukemia (APL) therapy remains unclear. In the present study, the signaling of the cytotoxic effects induced by As4S4 on retinoic acid-resistant APL NB4-R1 cells was investigated. A time-dependent increase in cell death and DNA cleavage was observed following As4S4 treatment. Changes in B-cell lymphoma 2 and Bax accompanied by the activation of caspase-3 and cleavage of poly ADP-ribose polymerase were observed as actions of As4S4. As4S4 induced an accumulation of NB4-R1 cells in the S and G2/M phases, as detected by flow cytometry. Therefore, the present results suggest that As4S4-mediated apoptosis in NB4-R1 cells involves a mitochondria-dependent pathway.

Entities:  

Keywords:  NB4-R1 cells; acute promyelocytic leukemia; apoptosis; cell cycle; tetra-arsenic tetra-sulfide

Year:  2015        PMID: 26171170      PMCID: PMC4486980          DOI: 10.3892/br.2015.466

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  16 in total

1.  Realgar-mediated growth inhibition on HaCaT human keratinocytes is associated with induction of apoptosis.

Authors:  Wai-Pui Tse; Christopher H K Cheng; Chun-Tao Che; Ming Zhao; Rui-Qiang Fan; Zhi-Xiu Lin
Journal:  Int J Mol Med       Date:  2009-08       Impact factor: 4.101

2.  Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial.

Authors:  Hong-Hu Zhu; De-Pei Wu; Jie Jin; Jian-Yong Li; Jun Ma; Jian-Xiang Wang; Hao Jiang; Sai-Juan Chen; Xiao-Jun Huang
Journal:  J Clin Oncol       Date:  2013-10-14       Impact factor: 44.544

3.  Role of gap junction intercellular communication in testicular leydig cell apoptosis induced by oxaliplatin via the mitochondrial pathway.

Authors:  Xuhui Tong; Xi Han; Binbin Yu; Meiling Yu; Guojun Jiang; Jie Ji; Shuying Dong
Journal:  Oncol Rep       Date:  2014-10-29       Impact factor: 3.906

Review 4.  Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics.

Authors:  Jean-Claude Martinou; Richard J Youle
Journal:  Dev Cell       Date:  2011-07-19       Impact factor: 12.270

5.  Condurango glycoside-rich components stimulate DNA damage-induced cell cycle arrest and ROS-mediated caspase-3 dependent apoptosis through inhibition of cell-proliferation in lung cancer, in vitro and in vivo.

Authors:  Sourav Sikdar; Avinaba Mukherjee; Samrat Ghosh; Anisur Rahman Khuda-Bukhsh
Journal:  Environ Toxicol Pharmacol       Date:  2013-12-15       Impact factor: 4.860

6.  Regulation of DNAS1L3 endonuclease activity by poly(ADP-ribosyl)ation during etoposide-induced apoptosis. Role of poly(ADP-ribose) polymerase-1 cleavage in endonuclease activation.

Authors:  A Hamid Boulares; Anna J Zoltoski; Francisco J Contreras; Alexander G Yakovlev; Koichiro Yoshihara; Mark E Smulson
Journal:  J Biol Chem       Date:  2001-11-01       Impact factor: 5.157

7.  Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group.

Authors:  P Fenaux; S Chevret; A Guerci; N Fegueux; H Dombret; X Thomas; M Sanz; H Link; F Maloisel; C Gardin; D Bordessoule; A M Stoppa; A Sadoun; P Muus; H Wandt; P Mineur; J A Whittaker; M Fey; M T Daniel; S Castaigne; L Degos
Journal:  Leukemia       Date:  2000-08       Impact factor: 11.528

8.  Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report.

Authors:  Dao-Pei Lu; Jing-Ying Qiu; Bin Jiang; Qin Wang; Kai-Yan Liu; Yan-Rong Liu; Shan-Shan Chen
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

9.  [Bcl-2 and Bax protein interaction in B-lymphocytes of peripheral blood in patients with chronic lymphocytic leukemia].

Authors:  Goran Brajusković; Slobodanka Vukosavić Orolicki; Snezana Cerović; Slavica Knezević Usaj; Slobodan Marjanović; Stanka Romac
Journal:  Vojnosanit Pregl       Date:  2005-05       Impact factor: 0.168

10.  Characterization of splice variants of human caspase-activated DNase with CIDE-N structure and function.

Authors:  José R Bayascas; Víctor J Yuste; Carme Solé; Isabel Sánchez-López; Miquel F Segura; Remei Perera; Joan X Comella
Journal:  FEBS Lett       Date:  2004-05-21       Impact factor: 4.124

View more
  5 in total

1.  Retinoic Acid Prevents Disruption of Blood-Spinal Cord Barrier by Inducing Autophagic Flux After Spinal Cord Injury.

Authors:  Yulong Zhou; Binbin Zheng; Libing Ye; Hongyu Zhang; Sipin Zhu; Xiaomeng Zheng; Qinghai Xia; Zili He; Qingqing Wang; Jian Xiao; Huazi Xu
Journal:  Neurochem Res       Date:  2015-11-18       Impact factor: 3.996

2.  Effect of alfalfa substituted with ramie on the expression of apoptotic genes in the gastrointestinal tracts of goats.

Authors:  Qian Liu; Chao Fu; Hai Yang; Chuanshe Zhou; Jinhe Kang; Liang Chen; Zhiwei Kong; Zhiliang Tan; Shaoxun Tang
Journal:  Food Sci Nutr       Date:  2022-04-01       Impact factor: 3.553

Review 3.  Pharmacology, Toxicology, and Rational Application of Cinnabar, Realgar, and Their Formulations.

Authors:  Huifang Guan; Yan Xu; Chunyu Ma; Dexi Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-27       Impact factor: 2.650

4.  Propofol inhibits proliferation, migration, and invasion but promotes apoptosis by regulation of Sox4 in endometrial cancer cells.

Authors:  Qing Du; Jia Liu; Xuezhi Zhang; Xin Zhang; He Zhu; Ming Wei; Shilei Wang
Journal:  Braz J Med Biol Res       Date:  2018-02-26       Impact factor: 2.590

5.  As4S4 Exhibits Good Killing Effect on Multiple Myeloma Cells Via Repressing SOCS1 Methylation-Mediated JAK2/STAT3 Signaling Pathway.

Authors:  Di Wu; Wei Dong; Kun Fang; Mengchang Wang
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.